Skip to main content
. 2021 Jun 1;5(6):e580. doi: 10.1097/HS9.0000000000000580

Figure 4.

Figure 4.

Transplantation platforms, associated dominant immune repertoires early after transplantation, and potential risk of GVHD induced by maintenance therapy. ATG = anti-thymocyte globulin; GVHD = graft vs host disease; NK = natural killer; PTCy = post-transplantation cyclophosphamide; SCT = stem cell transplantation.